title: Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.
authors: B
authors: B
authors: Karges
authors: D
authors: D
authors: Schnur
authors: S
authors: S
authors: Ellard
authors: H
authors: H
authors: Kentrup
authors: W
authors: W
authors: Karges
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000187:drug effects* / Q000235:genetics; D000293:Adolescent; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007231:Infant, Newborn; D008297:Male; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000187:drug effects* / Q000235:genetics; D011955:Receptors, Drug / Q000187:drug effects* / Q000235:genetics; D013453:Sulfonylurea Compounds / Q000008:administration & dosage*; D064233:Sulfonylurea Receptors; D000099161:Kcnj11 Channel
chemical_list: D018528:ATP-Binding Cassette Transporters; D007004:Hypoglycemic Agents; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D013453:Sulfonylurea Compounds; D064233:Sulfonylurea Receptors; D000099161:Kcnj11 Channel; C577507:ABCC8 protein, human; C057619:glimepiride